News
FDA reviewer pokes holes in Geron’s MDS drug data
Geron could have a tougher time than it anticipated at tomorrow’s FDA advisory committee meeting for myelodysplastic syndromes (MDS) drug candidate imetelstat.
Friday 13 February 2026
